163 related articles for article (PubMed ID: 24243872)
1. Gonococcal antimicrobial resistance: the implications for public health control.
Ndowa FJ; Ison CA; Lusti-Narasimhan M
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872
[No Abstract] [Full Text] [Related]
2. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme.
Hançali A; Ndowa F; Bellaji B; Bennani A; Kettani A; Charof R; El Aouad R
Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv24-7. PubMed ID: 24037141
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004.
WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme
Commun Dis Intell Q Rep; 2006; 30(1):129-32. PubMed ID: 16637241
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and genotypic distribution of Neisseria gonorrhoeae: a 2-year study in Tunisia.
Ferjani A; Marzouk M; Saghrouni F; Hadj Ali M; Boukadida J
Med Mal Infect; 2013 May; 43(5):211-2. PubMed ID: 23623306
[No Abstract] [Full Text] [Related]
6. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance in Neisseria gonorrhoeae.
Tapsall JW
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic susceptibility of Neisseria gonorrhoeae in Guadalajara area].
Arias M; Tena D; Bisquert J
Rev Esp Quimioter; 2011 Mar; 24(1):48-9. PubMed ID: 21412670
[No Abstract] [Full Text] [Related]
9. Trends in antimicrobial susceptibility of Neisseria gonorrhoeae in Israel, 2002 to 2007, with special reference to fluoroquinolone resistance.
Dan M; Mor Z; Gottliev S; Sheinberg B; Shohat T
Sex Transm Dis; 2010 Jul; 37(7):451-3. PubMed ID: 20562585
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.
Vázquez JA; Martín E; Galarza P; Giménez MJ; Aguilar L; Coronel P
Int J Antimicrob Agents; 2007 Apr; 29(4):473-4. PubMed ID: 17276040
[No Abstract] [Full Text] [Related]
12. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network.
Smith DW; Tapsall JW; Lum G
Commun Dis Intell Q Rep; 2005; 29(4):358-65. PubMed ID: 16465924
[TBL] [Abstract][Full Text] [Related]
13. Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988 and 1989.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1990 May; 39(17):284-7, 293. PubMed ID: 2139166
[No Abstract] [Full Text] [Related]
14. Antimicrobial sensitivity of Neisseria gonorrhoeae: a hospital-based study from Kuwait.
Sharma AK; Al-Mutairi N; Zaki A; Nour-Eldin O; Joshi A; Rijhwani M; Al-Tayeh MY; Sultan AM
J Chemother; 2005 Feb; 17(1):117-8. PubMed ID: 15828455
[No Abstract] [Full Text] [Related]
15. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
Ndowa F; Lusti-Narasimhan M; Unemo M
Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629
[No Abstract] [Full Text] [Related]
16. Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.
Chan CH; McCabe CJ; Fisman DN
Sex Transm Infect; 2012 Apr; 88(3):200-4. PubMed ID: 22169277
[TBL] [Abstract][Full Text] [Related]
17. Update on antimicrobial susceptibility and genotype of Neisseria gonorrhoeae isolated in Italy.
Carannante A; Latini A; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):288-90. PubMed ID: 22321999
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
Moodley P; Moodley D; Willem Sturm A
Int J Antimicrob Agents; 2004 Aug; 24(2):192-3. PubMed ID: 15288322
[No Abstract] [Full Text] [Related]
19. [The monitoring of Neisseria gonorrhoeae infection incidence and its resistance in Suceava County].
Filipiuc S; Nicolae O; Luncă C; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1238-42. PubMed ID: 20191906
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
Chan DJ; Tapsall J
Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
